Prospective Multicenter Single-Arm Study of Vanquish Water Vapor Ablation for PrOstate CanceR (VAPOR 2 Study)
Brief description of study
The purpose of this study is to evaluate the safety and effectiveness of the Vanquish Water Vapor Ablation Device (“Vanquish”) in subjects with Gleason Grade Group 2 (GGG2) localized intermediate-risk prostate cancer.
Clinical Study Identifier: s23-00203
ClinicalTrials.gov Identifier: NCT05683691
If you are registered as a volunteer, please log in to contact the study team/express interest in this study.
